Asian Pacific Journal of Cancer Prevention

  • 제15권13호
  • /
  • Pages.5337-5341
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers

  • Cihan, Sener (Department of Medical Oncology, Okmeydani Education and Research Hospital) ;
  • Kucukoner, Mehmet (Department of Medical Oncology, Dicle University Faculty of Medicine) ;
  • Ozdemir, Nuriye (Department of Medical Oncology, Yildirim Beyazit University) ;
  • Dane, Faysal (Department of Medical Oncology, Marmara University Faculty of Medicine) ;
  • Sendur, Mehmet Ali Nahit (Department of Medical Oncology, Yildirim Beyazit University) ;
  • Yazilitas, Dogan (Department of Medical Oncology, Yildirim Beyazit University) ;
  • Urakci, Zuhat (Department of Medical Oncology, Dicle University Faculty of Medicine) ;
  • Durnali, Ayse (Department of Medical Oncology, Ankara Demetevler Research and Education Hospital) ;
  • Yuksel, Sinemis (Department of Medical Oncology, Lutfi Kirdar Kartal Education and Research Hospital) ;
  • Aksoy, Sercan (Department of Medical Oncology, Hacettepe University Cancer Institute) ;
  • Colak, Dilsen (Department of Medical Oncology, Diskapi Yildirim Bayazit Education and Research Hospital) ;
  • Seker, Mehmet Metin (Department of Medical Oncology, Cumhuriyet University Faculty of Medicine) ;
  • Taskoylu, Burcu Yapar (Department of Medical Oncology, Pamukkale University Faculty of Medicine) ;
  • Oguz, Arzu (Department of Medical Oncology, Kayseri Education and Research Hospital) ;
  • Isikdogan, Abdurrahman (Department of Medical Oncology, Dicle University Faculty of Medicine) ;
  • Zengin, Nurullah (Department of Medical Oncology, Ankara Numune Education and Research Hospital)
  • 발행 : 2014.07.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: The standard therapy for stage I rectum cancer is surgical resection. Currently, there is no strong evidence to suggest that any type of adjuvant therapy is beneficial. The risks of local relapse and distant metastasis are higher in rectal tumors. Therefore, while there is no clearly defined absolute indication for adjuvant therapy in lymph node negative colon cancers, rectum tumors that are T3N0 and higher require adjuvant treatment. Due to the more aggressive nature of rectal cancers, we explored the clinical and pathologic factors that could predict the risk of relapse in Stage I (T1-T2) disease and whether there was any progression-free survival benefit to adjuvant therapy. Materials and Methods: This multicenter study was carried out by the Anatolian Society of Medical Oncology. A total of 178 patients with rectal cancers who underwent curative surgery between January 1994 and August 2012 in 13 centers were included in the study. Patient demographics, including survival data and tumor characteristics were obtained from medical charts. Results: The median age was 58 years (range 26-85 years). Most tumors were well or moderately differentiated. For adjuvant treatment, 13 patients (7.3%) received radiotherapy alone, 12 patients (6.7%) received chemotherapy alone and 15 patients (8.4%) were given chemoradiotherapy. Median follow up was 29 months (3-225 months). Some 42 patients (23.6%) had relapse during follow up; 30 with local recurrence (71.4%) whereas 12 (28.6%) were distant metastases. Among the patients, 5-year DFS was 64% and OS was 82%. Mucinous histology and receiving adjuvant therapy were found to have statistically insignificant correlations with relapse and survival. Conclusions: In our retrospective analysis, approximately one quarter of patients exhibited either local or systemic relapse. The rates of relapse were slightly higher in the patients who had no adjuvant therapy. There may thus be a role for adjuvant therapy in high-risk stage I rectal tumors.

키워드

참고문헌

  1. Arbman G, Nilsson E, Hallbik O, et al (1996). Local reccurence following total mesorectal excision for rectal cancer. Br J Surg, 83, 375-9. https://doi.org/10.1002/bjs.1800830326
  2. Bailey HR, Huval WV, Max E, et al (1992). Local excision of carcinoma of the rectum for cure. Surgery, 111, 555-1.
  3. Bas K, Guler T, Gunay LM, et al (2012). Public awareness of colorectal cancer in a turkish population: importance of fecal occult blood testing. Asian Pac J Cancer Prev, 13, 195-8 https://doi.org/10.7314/APJCP.2012.13.1.195
  4. Bleday R, Breen E, Jessup JM, et al (1997). Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum, 40, 388-2. https://doi.org/10.1007/BF02258381
  5. Bleday R. (1997). Local excision of rectal cancer. World J Surg, 21, 706-4. https://doi.org/10.1007/s002689900295
  6. Blumberg D, Paty PB, Guillem JG, et al (1999). All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum, 42, 881-5. https://doi.org/10.1007/BF02237095
  7. Bouvet M, Milas M, Giacco GG, et al (1999). Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol, 6, 26-2. https://doi.org/10.1007/s10434-999-0026-3
  8. By JE, Tepper M, O'Connell, et al (2002). Adjuvant therapy in rectal cancer: analysis of stage, sex and local control-final report of intergroup. J Clin Oncol, 20, 1744-0. https://doi.org/10.1200/JCO.2002.07.132
  9. Can Zhou, Yu Ren, Ke Wang, et al (2013). Intra-operative rectal washout with saline solution can effectively prevent anastomotic recurrence: a meta analysis. Asian Pac J Cancer Prev, 14, 7155-9. https://doi.org/10.7314/APJCP.2013.14.12.7155
  10. Carlsen E, Schlichting E, Guldvog I, et al (1998). Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg, 85, 526-9. https://doi.org/10.1046/j.1365-2168.1998.00601.x
  11. Chakravarti A, Compton CC, Shellito PC, et al (1999). Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg, 230, 49-4. https://doi.org/10.1097/00000658-199907000-00008
  12. Compton CC, Fielding LP, Burgart LJ, et al (2000). Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement, 1999. Arch Pathol Lab Med, 124, 979-94.
  13. Enker WE, Thaler HT, Cranor ML, et al (1995). Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg, 181, 335-46.
  14. Fortunato L, Ahmad NR, Yeung RS, et al (1995). Long-term follow-up of local excision and radiation therapy for invasive rectal cancer. Dis Colon Rectum, 38, 1193-9. https://doi.org/10.1007/BF02048336
  15. Havenga K, Enker WE, Norstein J, et al (1999). Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients. Eur J Surg Cancer, 25,368-4
  16. Heald RJ, Moran BJ, Ryall RD, et al (1998). Rectal cancer: The Basingstoke experience of total mesorecal excision, 1978-1997. Arch Surg, 133, 894-9.
  17. Jemal A, Siegel R, Ward E (2008). Cancer statistics 2008. CA Cancer J Clin, 58, 71-96, https://doi.org/10.3322/CA.2007.0010
  18. Jessup JM, Stewart AK, Menck HR (1998). The national cancer data base report on patterns of care for adenocarcinoma of the rectum, 1985-1995. Cancer, 83, 2408-8. https://doi.org/10.1002/(SICI)1097-0142(19981201)83:11<2408::AID-CNCR22>3.0.CO;2-G
  19. Leo E, Belli F, Andreola S, et al (2000). Total rectal resection and complete mesorectal excision followed by coloendoanal anastomosis as the optimal treatment for low rectal cancer: The experience of the National Cancer Institute of Milano. Ann Surg Oncol, 7, 125-2. https://doi.org/10.1007/s10434-000-0125-7
  20. Madhulika G, Varma MD, Stanley J, et al (1999). Local excision of rectal carcinoma. Arch Surg, 134, 863-8. https://doi.org/10.1001/archsurg.134.8.863
  21. Mellgren A, Sirivongs P, Rothenberger DA, et al (2000). Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum, 43, 1064-1. https://doi.org/10.1007/BF02236551
  22. Minsky BD, Mies C, Recht A, et al (1988). Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival. Cancer, 61, 1408 https://doi.org/10.1002/1097-0142(19880401)61:7<1408::AID-CNCR2820610722>3.0.CO;2-A
  23. Minsky BD, Enker WE, Cohen AM, et al (1994). Local excision and postoperative radiation therapy for rectal cancer. Am J Clin Oncol, 17, 411-6. https://doi.org/10.1097/00000421-199410000-00011
  24. Morson BC, Bussey HJ, Samoorian S (1977). Policy of local excision for early cancer of the colorectum. Gut, 18, 1045-0. https://doi.org/10.1136/gut.18.12.1045
  25. Nascimbeni R, Burgart L, Nivatvongs S, et al (2002). Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum, 45, 200-6. https://doi.org/10.1007/s10350-004-6147-7
  26. Nagtegaal ID, Quirke P (2008). What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol, 26, 303-12. https://doi.org/10.1200/JCO.2007.12.7027
  27. Nelson H, Petrelli N, Carlin A (2001). Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst, 93, 583-96. https://doi.org/10.1093/jnci/93.8.583
  28. NIH Consensus Conference. (1990). Adjuvant therapy for patients with colon and rectal cancer. JAMA, 264, 1444-0. https://doi.org/10.1001/jama.1990.03450110090034
  29. Ota DM SJ, Rich TA (1992). M. D. Anderson Cancer Center experience with local excision and multimodality therapy for rectal cancer. Surg Oncol Clin North Am, 1, 147-2.
  30. Ozdemir Y, Akin ML, Sucullu I, et al (2014). Pretreatment neutrophil/lymphocyte ratio as a prognostic aid in colorectal cancer. Asian Pac J Cancer Prev, 15, 2647-0. https://doi.org/10.7314/APJCP.2014.15.6.2647
  31. Paty PB, Nash GM, Baron P, et al (2002) Long-term results of local excision for rectal cancer. Ann Surg. 236, 522-30. https://doi.org/10.1097/00000658-200210000-00015
  32. Russell AH, Harris J, Rosenberg P, et al (2000). Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of Radiation Therapy Oncology Group protocol 89-02. Int J Radiation Oncology Biol Phys, 46, 313-2. https://doi.org/10.1016/S0360-3016(99)00440-X
  33. Steele GD, Herndon JE, Bleday R, et al (1999). Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol, 6, 433-1. https://doi.org/10.1007/s10434-999-0433-5
  34. Taylor RH, Hay JH, Larsson SN. (1998). Transanal local excision of selected low rectal cancers. Am J Surg, 175, 360-3. https://doi.org/10.1016/S0002-9610(98)00038-5
  35. Tong G, Chai J, Cheng J, et al (2014). Diagnostic value of rectal bleeding in predicting colorectal cancer: a systematic review. Asian Pac J Cancer Prev, 15, 1015-1 https://doi.org/10.7314/APJCP.2014.15.2.1015
  36. Weber TK, Petrelli NJ. (1998). Local excision for rectal cancer; an uncertain future. Oncology, 12, 933-3.
  37. Zaheer S, Pemberton JH, Farouk R, et al (1998). Surgical treatment of adenocarcinoma of the rectum. Ann Surg. 227, 800-11. https://doi.org/10.1097/00000658-199806000-00003